Exclusive

Publication

Byline

Location

US Patent Issued to JANSSEN BIOTECH on Aug. 4 for "Subcutaneous formulations of anti-CD38 antibodies and their uses" (Pennsylvania Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,337, issued on Aug. 4, was assigned to JANSSEN BIOTECH INC. (Horsham, Pa.). "Subcutaneous formulations of anti-CD38 antibodies and their use... Read More


US Patent Issued to BLACK BELT THERAPEUTICS on Aug. 4 for "CD38 modulating antibody" (British, American Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,338, issued on Aug. 4, was assigned to BLACK BELT THERAPEUTICS Ltd. (Stevenage, Great Britain). "CD38 modulating antibody" was invented by P... Read More


US Patent Issued to Keio University, Iwate Medical University on Aug. 4 for "Anti-glypican-1-immunizing antigen receptor" (Japanese Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,339, issued on Aug. 4, was assigned to Keio University (Tokyo) and Iwate Medical University (Iwate, Japan). "Anti-glypican-1-immunizing anti... Read More


US Patent Issued to ADICET THERAPEUTICS on Aug. 4 for "Compositions and methods regarding engineered and non-engineered GammaDelta T-cells for treatment of solid tumors" (California Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,340, issued on Aug. 4, was assigned to ADICET THERAPEUTICS INC. (Redwood City, Calif.). "Compositions and methods regarding engineered and n... Read More


US Patent Issued to Xencor on Aug. 4 for "Antigen binding domains that bind to mesothelin (MSLN)" (California Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,341, issued on Aug. 4, was assigned to Xencor Inc. (Pasadena, Calif.). "Antigen binding domains that bind to mesothelin (MSLN)" was invented... Read More


US Patent Issued to JIANGSU ALPHAMAB BIOPHARMACEUTICALS on Aug. 4 for "Combination of bispecific fusion protein and anti-Her2 antibody for tumor treatment" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,343, issued on Aug. 4, was assigned to JIANGSU ALPHAMAB BIOPHARMACEUTICALS Co. LTD. (Suzhou, China). "Combination of bispecific fusion prote... Read More


US Patent Issued to Ramot at Tel-Aviv University on Aug. 4 for "Anti-IDE antibodies and uses of same" (Israeli Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,344, issued on Aug. 4, was assigned to Ramot at Tel-Aviv University Ltd. (Tel-Aviv, Israel). "Anti-IDE antibodies and uses of same" was inve... Read More


US Patent Issued to Kashiv BioSciences on Aug. 4 for "Process for improving Omalizumab expression in CHO cells" (Indian Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,345, issued on Aug. 4, was assigned to Kashiv BioSciences LLC (Piscataway, N.J.). "Process for improving Omalizumab expression in CHO cells"... Read More


US Patent Issued to XOMA (US) on Aug. 4 for "Parathyroid hormone receptor 1(PTH1R) antibodies and uses thereof" (California Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,346, issued on Aug. 4, was assigned to XOMA (US) LLC (Emeryville, Calif.). "Parathyroid hormone receptor 1(PTH1R) antibodies and uses thereo... Read More


US Patent Issued to Silver Creek Pharmaceuticals on Aug. 4 for "Bi-specific fusion proteins" (Massachusetts, California, Washington Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,347, issued on Aug. 4, was assigned to Silver Creek Pharmaceuticals Inc. (San Francisco). "Bi-specific fusion proteins" was invented by Ulri... Read More